Q4 2025 earnings call recap: record $2.2B order book, APA integration, and 2026 revenue/EBITDA outlook—read now.
Shares of Replimune Group, Inc. (REPL) have gained 0.7% over the past four weeks to close the last trading session at $7.76, but there could still be a solid upside left in the stock if short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results